Prostaglandin receptors EP1-4 as a potential marker for clinical outcome in urothelial bladder cancer. - Wikidata - awgldk - TriplyDB

Prostaglandin receptors EP1-4 as a potential marker for clinical outcome in urothelial bladder cancer.

Prostaglandin receptors EP1-4 as a potential marker for clinical outcome in urothelial bladder cancer.

http://www.wikidata.org/entity/Q34705013

about

Prostaglandin E2 promotes human CD34+ cells homing through EP2 and EP4 in vitro.Decursinol angelate inhibits PGE2-induced survival of the human leukemia HL-60 cell line via regulation of the EP2 receptor and NFκB pathway.Activation of PGE2/EP2 and PGE2/EP4 signaling pathways positively regulate the level of PD-1 in infiltrating CD8+ T cells in patients with lung cancer.Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression.Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer.

P2860

Q33828142-270C3B4E-DBCF-43F5-99AF-6150DAEC0381 Q36077235-7CF071DD-FFE6-428C-8592-7F2CB9DE19FE Q47100323-16914BB9-0C66-4A4E-A776-582A5980AA33 Q50082353-5B1B4BC5-EFBF-4FB3-A5BC-134C31B2B17F Q52668195-C3BF4965-E5B4-4879-82D0-B06EB819D432

P2860

Prostaglandin receptors EP1-4 as a potential marker for clinical outcome in urothelial bladder cancer.

http://www.wikidata.org/entity/Q34705013

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Prostaglandin receptors EP1-4 ...... in urothelial bladder cancer.

@ast

Prostaglandin receptors EP1-4 ...... in urothelial bladder cancer.

@en

Prostaglandin receptors EP1-4 ...... in urothelial bladder cancer.

@nl

type

label

Prostaglandin receptors EP1-4 ...... in urothelial bladder cancer.

@ast

Prostaglandin receptors EP1-4 ...... in urothelial bladder cancer.

@en

Prostaglandin receptors EP1-4 ...... in urothelial bladder cancer.

@nl

prefLabel

Prostaglandin receptors EP1-4 ...... in urothelial bladder cancer.

@ast

Prostaglandin receptors EP1-4 ...... in urothelial bladder cancer.

@en

Prostaglandin receptors EP1-4 ...... in urothelial bladder cancer.

@nl

P1433

Q34705013-403CCA9C-1EDD-450E-817A-5D6C9CC251B4

P1476

Q34705013-B180C7E0-336A-41D7-98F9-336334B6297C

P2093

Q34705013-0446BE9F-8819-45D9-A012-97042F8BB0C5

Q34705013-216656A6-C358-46BE-9B47-7C791723CA31

Q34705013-35B4CB8B-15B3-49E2-8A59-024BEDC20E02

Q34705013-48BB95FF-C1C2-471C-9804-3142309981FC

Q34705013-56165D79-0CF5-4963-AA43-B91FC44897E7

Q34705013-62D53ABD-AE8A-4A7C-A609-683A6B42109C

Q34705013-77A18B02-05E7-4730-AAF1-0CC09BD72221

P2860

Q34705013-06A15AEB-2148-4421-9ACF-DDF5A8CC3966

Q34705013-0BCBA13D-4CD6-4174-8CAC-64B0DC5B83FA

Q34705013-152FE5CD-05F7-46F5-B861-A81A44339ED6

Q34705013-20B265CD-4629-4C2B-9B95-2201DB2F522E

Q34705013-2A1AE0B5-BEE6-4700-B849-0A76862292E1

Q34705013-30632BAA-D4CE-46F2-ADC6-B2015B401071

Q34705013-3B0A0A81-5B06-4E23-813B-F26A14B9B0F4

Q34705013-3B601D19-A264-4921-86C9-84C45670ADCB

Q34705013-3EAB0C64-7F91-4B88-93F3-0C5CAA528569

Q34705013-42BB279E-9103-4353-BA51-F3CFF1FC5056

P304

Q34705013-2A5F24B6-D57B-4155-A76C-3D1DE94BB680

P31

Q34705013-C54EA5DE-F5C7-457B-89CC-3FF3AEFCFAE9

P433

Q34705013-200E5D91-9B01-4BE1-B784-348B237D589C

P478

Q34705013-B53B718B-2801-4D4E-86D2-8E748045440E

P577

Q34705013-DA241D35-0DC5-416E-8F13-7251CB2D9EFB

P698

Q34705013-8BCBB4F7-9B86-49A0-9214-ACBE01870369

P932

Q34705013-BDCA7A22-D938-4F41-8BA3-299B1253E8E8

P1433

American Journal of Cancer Research

P1476

Prostaglandin receptors EP1-4 ...... e in urothelial bladder cancer

@en

P2093

Diane Goltz

http://www.w3.org/2001/XMLSchema#string

Glen Kristiansen

http://www.w3.org/2001/XMLSchema#string

Isabella Syring

http://www.w3.org/2001/XMLSchema#string

Jörg Ellinger

http://www.w3.org/2001/XMLSchema#string

Laura von der Emde

http://www.w3.org/2001/XMLSchema#string

Stefan C Müller

http://www.w3.org/2001/XMLSchema#string

Stefan Latz

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2014

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis

Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells

Identification of prostaglandin receptors in human ureters.

PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis.

Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities.

Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions.

The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia.

Pathobiology and chemoprevention of bladder cancer

P304

952-962

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25520883

http://www.w3.org/2001/XMLSchema#string

P932

4266727

http://www.w3.org/2001/XMLSchema#string